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Available online 8 June 2011Background: Although there are disability weights available for a wide range of health states,
these do not include suicidality. This makes it difficult to evaluate the severity of suicidality in
comparison with other health states. The aim of this study therefore is to estimate disability
weights for suicidal thoughts and for mental distress involved in non-fatal suicide attempts.
Methods: A Dutch expert panel of sixteenmedical practitioners whowere knowledgeable about
suicidality estimated disability weights (DWs) for twelve health states by interpolating them
on a calibrated Visual Analogue Scale. The DWs for ten of these health states had been
estimated in previous studies and were used to determine the external consistency of the
panel. The other two concerned health states for suicidal thoughts and non-fatal suicide
attempts. The resulting DWs could vary between 0 (best imaginable health state) and 1 (worst
imaginable health state).
Results: Both internal (Cronbach's α=0.98) and external consistency of the panel were
satisfactory. The DWs for suicidal thoughts and non-fatal suicide attempts were estimated to be
0.36 and 0.46 respectively.
Limitations: The panel was relatively small, which resulted in broad confidence intervals.
Conclusions: Suicidal thoughts are considered to be as disabling as alcohol dependence and
severe asthma. The mental distress involved in non-fatal suicide attempts is thought to be
comparable in disability to heroin dependence and initial stage Parkinson's. These results
demonstrate the severity of suicidality.






Disability adjusted life year1. Introduction
Suicidal behavior is a major public health problem
worldwide. With approximately 1 million people dying by
suicide each year it is among the leading causes of death,
especially among those aged 15–44 years (Nock et al., 2008;Psychology, Faculty of
an der Boechorststraat
9 88497; fax: +31 20
n Spijker).
lsevier OA license.WHO, 2008b). In the Netherlands, around 1500 people die by
suicide each year (Statistics Netherlands, 2010). In addition,
an estimated 99,600 suicide attempts occur each year (0.9%
of the Dutch adult population) (Hoeymans and Schoemaker,
2010; Ten Have et al., 2006) About 14,000 (15%) of these
persons attempting suicide are treated in an emergency
room, of whom 9500 are admitted to a hospital (Kerkhof
et al., 2007). Another 8200 attempts (9%) are treated by
general physicians (Marquet et al., 2005). From these ﬁgures
it becomes apparent that the majority of attempts (76%)
remain untreated or do notwarrantmedical intervention. The
year-prevalence of suicidal thoughts in the Netherlands is
3.2% (Ten Have et al., 2006), which amounts to approximately
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Schoemaker, 2010).
Suicidal thoughts and suicide attempts may occur in a
number of psychiatric disorders. Psychological autopsy
studies show that 90%–95% of people who die by suicide
had a diagnosable psychiatric disorder at the time of the
suicide (Cavanagh et al., 2003). The most prevalent diseases/
conditions are depression, alcohol/substance use, psychotic
disorders, impulse–control disorders, and personality disor-
ders (Nock et al., 2008). While often perceived to be a
symptom of psychiatric disorders, it has also been suggested
that suicidality can be regarded as a separate syndrome or
DSM-V axis (Ahrens and Linden, 1996; Oquendo et al., 2008).
Core symptoms of this suicidality syndrome are hopelessness,
ruminative thinking and social withdrawal (Ahrens and
Linden, 1996).
More than mortality and prevalence alone, burden of
disease has become an important indicator of a population's
health. Burden of disease can be described as the impact of a
health problem on the population measured by mortality and
morbidity. It is most frequently quantiﬁed by Disability
Adjusted Life Years (DALYs). DALYs express both the loss of
healthy life years due to premature death (Years of Life Lost,
YLL) and the loss of healthy life years due to disability (Years
Lived with Disability, YLD). One DALY therefore represents
the loss of the equivalent of 1 year in full health. YLD for a
particular health state are estimated by multiplying the
incidence of a health state by the average duration of the
disease and the disability weight (DW). The DW is an index
between 0 (best imaginable health state) and 1 (worst
imaginable health state), which expresses the severity of the
disability associated with a certain health state. The DALY is
described in detail in Murray and Lopez (1996).
In general, DWs are estimated using an expert panel, a
patient panel or a general public panel, dependent upon the
perspective of the researchers and the aim of the study. In
epidemiological studies, in which DALYs are used to compare
population health, expert panels are often used to estimate
DWs. In cost-effectiveness studies, patient or general public
panels are more often used to estimate utilities (the
complement of DWs) and calculate Quality Adjusted Life
Years (QALYs) (Gold et al., 2002). Both DALYs and QALYs have
underlying assumptions which are not without controversy,
and methods to estimate DWs and utilities continue to be a
point of discussion (Anand and Hanson, 1997; Brazier, 2008;
Mont, 2007; Murray et al., 2000; Nord et al., 2009). The study
described in this paper has been conducted from an
epidemiological perspective and therefore focuses on DWs
and DALYs, which is in line with previous studies that
estimated DWs for health states (e.g. Mathers et al., 1999;
Murray and Lopez, 1996).
Disability weights (DWs) have been estimated for many
health states (Murray and Lopez, 1996; Stouthard et al., 1997;
Stouthard et al., 2000; Vos et al., 2001), including self-inﬂicted
injuries (DW=0.447) (Mathers et al., 1999). For burden of
disease studies, self-inﬂicted injuries have been deﬁned as
“suicide attempts, whether or not resulting in death”
(Harvard Initiative for Global Health, 2009). In 2004, self-
inﬂicted injuries represented 1.3% of the global burden of
disease, which places them among the leading causes of
disease burden worldwide (WHO, 2008a). In a recent six yearfollow-up study of a clinical sample of self-harm patients,
Sinclair et al. (2010) conclude that in this group “mortality,
morbidity and perceived quality of life (…) were signiﬁcantly
worse (…) than in the general population” (Sinclair et al.,
2010, p. 250).
Suicidal thoughts are not included in the deﬁnition of self-
inﬂicted injuries, but may contribute to the overall burden of
suicidality. The ﬁrst aim of this study therefore is to estimate
the DW for suicidal thoughts. The second aim of this study is




The valuation procedure was carried out by mail with the
help of an expert panel (see ‘panel’). Each panelist received
descriptions of twelve health states (see ‘Health states’)
which they were asked to interpolate on a Visual Analogue
Scale (VAS), ranging from 0 (worst imaginable health state)
to 100 (best imaginable health state). For the interpolation,
they were instructed to consider the consequences of living
with the health state for 1 year, unless otherwise speciﬁed.
The VAS has been formally calibrated with 16 health states
in the Dutch disability weights study using the person
trade off (PTO) method (Stouthard et al., 2000). The PTO
method is the preferred method for estimating DWs for
burden of disease studies since it attempts to measure social
preference instead of individual preferences more directly
than other methods (Nord, 1995). Since the PTO method is
a relatively complex one, this study used the calibrated VAS
to value health states. Panelists received the calibrated
VAS and the corresponding descriptions of the 16 reference
points. The original calibrated VAS has been published in
Stouthard et al. (2000).
The interpolation on the VAS results in a value between
0 and 100 for each health state. Since 0 represents the worst
imaginable health state and 100 the best imaginable health
state, the interpolated values correspond to so-called Utilities
on a scale from 0 to 1 (after dividing them by 100). A utility
(U) relates to a DW as DW=1−U. In the Dutch disability
weight study (Stouthard et al., 1997) utilities were published.
In order to be able to compare our DWs to the utilities from
Stouthard et al., these utilities were converted to DWs.
2.2. Panel
Members of the expert panel were selected on the basis of
three criteria. First, panelists had to be experienced medical
practitioners. This was required because they needed to value
a wide range of medical conditions. Second, a background in
research was required since understanding the concept and
usefulness of the DALY is important when valuing health
states. Finally, panelists needed to be knowledgeable about
suicidality. Panelists were recruited through personal net-
works of the authors.
In total, 26 experts were invited to participate. Six of
them indicated they were unable to take part in the study
(mostly due to lack of time), and two could not be reached.
The remaining 18 received the set of necessary documents.
Suicidality  
Suicidality is divided into the following stages: 
1. Suicidal thoughts 
2. Non-fatal suicide attempt 
We now ask you to value: 
People with suicidal thoughts 
These people experience one or more periods of 
suicidal thoughts within a year. During these 
periods they think about death and ask 
themselves if they would be better off dead. 
They possibly make a concrete plan, but they 
do not attempt suicide. The majority have a 
psychiatric condition; a minority receive 
treatment.
In a year, their condition is characterised by*: 
    No problems in walking about 
    No problems with self-care 
•• Some problems with performing daily
activities (e.g. work, study, housework, family 
or leisure activities)
•• Moderate pain or discomfort (fatigue)
•• Moderate anxiety or depression 
•  Few cognitive impairments (with memory, 
concentration, disorganization, IQ level)
Box 1. Health state description for attempted suicide.* No bullet = no
problems, 1 bullet = few problems, 2 bullets = some or moderate problems,
3 bullets = severe problems, 4 bullets = severe problems or incapacity.
343B.A.J. van Spijker et al. / Journal of Affective Disorders 134 (2011) 341–347The sixteen experts who returned the set formed the ﬁnal
panel.
2.3. Health states
Ten health states for which DWs had been previously
established were selected for this study in order to compare
our panel to previously used panels. These health states
needed to represent a broad range of DWs, include both acute
and chronic diseases, and take both physical and psychiatric
disorders into account. The selected health states were:
meningitis with permanent locomotor impairment
(DW=0.17), meningitis with permanent locomotor and
cognitive impairment (DW=0.76), constitutional eczema
(DW=0.07), moderate rheumatoid arthritis (DW=0.37),
moderate heart failure (DW=0.35), severe heart failure
(DW=0.65) (Stouthard et al., 2000), severe depression with
psychotic features (DW=0.84), moderate to severe depres-
sion (DW=0.51) (Kruijshaar et al., 2005), cataract
(DW=0.11) and macular degeneration (DW=0.25) (De
Hollander et al., 2006).
Each health state consisted of a descriptive text based on
criteria from the International Classiﬁcation of Diseases 10th
revision (ICD-10) (WHO, 2007) and the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV-TR) (American
Psychiatric Association, 2000). In addition, a standardized
health classiﬁcation derived from the EuroQol 5D+C5L
(Janssen et al., 2008a; Janssen et al., 2008b; Krabbe et al.,
1999) was added to the description. This rates the condition
on six dimensions (mobility, self-care, usual activities, pain/
discomfort, anxiety/depression and cognition) on a ﬁve-level
scale (no problems to severe problems).
For suicidal thoughts and non-fatal suicide attempt (see
De Leo et al., 2006 for the deﬁnitions), no DSM-IV-TR or ICD-
10 criteria were available. The authors therefore composed
these textual descriptions. The EuroQol descriptions of these
health states were based on data from the Netherlands
Mental Health Survey and Incidence Study (NEMESIS) (Ten
Have et al., 2006). The eight scales of the Short Form-36
health survey (SF-36) (Ware et al., 1993) and two additional
questions were used to indicate disability. These two
additional questions were about the number of days spent
in bed due to psychiatric problems, drug-related problems or
alcohol-related problems, and the number of days being
unable to work due to any of these problems. A formal
algorithm (available from the authors on request) was used
to transform the SF-36 data into EuroQol 5D+C5L classiﬁca-
tions (Kruijshaar et al., 2005). Boxes 1 and 2 provide the full
descriptions of suicidal thoughts and non-fatal suicide
attempt.
2.4. Statistical analyses
Before calculating the mean DWs for suicidal thoughts
and non-fatal suicide attempts we had to ascertain the
reliability of the panel. First, the internal consistency of
the panel was determined (a) by calculating Cronbach's
alpha and (b) by calculating Pearson correlation coefﬁ-
cients and paired sample t-tests in which each panelist
was compared with the mean of the other panelists in
order to identify possible outliers (i.e. panelists whovalued health states systematically different from the
mean of the panel).
Second, the external consistency of the panel was
determined by using ten health states for which DWs had
previously been estimated (see ‘Health states’). These DWs
were compared to the DWs of our panel using Pearson
correlation coefﬁcients and paired sample t-tests. In
addition, a graph was constructed to visually inspect
potential differences. Analyses were performed using
SPSS 16.0.
3. Results
3.1. Characteristics of the panel
Most of the panelists are male (93.8%). Mean age of the
panel is 54.6 years (SD=5.24), and the mean number of
years in the medical profession is 25 (SD=6.83). The
majority have a research background at PhD level (87.5%).
Regarding specialism, 62.5% are psychiatrists and 37.5% are
general practitioners. The majority are currently involved in
patient care (81.2%).
3.2. Internal consistency of the panel
The reliability analysis demonstrates an excellent agree-
ment among the panelists (Cronbach's α=0.98). Excluding
oneor anotherpanelistdoesnot improve theoverall Cronbach's
α. The paired sample t-tests and Pearson correlations between
Suicidality
Suicidality is divided into the following stages: 
1. Suicidal thoughts 
2. Non-fatal suicide attempt 
We now ask you to value: 
People who attempted suicide 
These people attempted suicide one or more 
times within a year, without a fatal outcome. The 
majority made a concrete plan prior to the 
attempt. Almost half do not have the intention to 
die; for them the attempt was a ‘cry for help’. 
After the attempt they are possibly treated at a 
hospital or by the GP.  The majority have a 
psychiatric condition. A minority receive 
treatment.
In a year, their condition is characterised by*: 
    No problems in walking about 
    No problems with self-care 
•• Some problems with performing daily 
activities (e.g. work, study, housework, family or 
leisure activities)
•• Moderate pain or discomfort (fatigue)
•• Moderate anxiety or depression 
•• Moderate cognitive impairments (with
memory, concentration, disorganization, IQ 
Box 2. Health state description for suicidal thoughts.* No bullet = no
problems, 1 bullet = few problems, 2 bullets = some or moderate problems,
3 bullets = severe problems, 4 bullets = severe problems or incapacity.
Table 1
Internal consistency. Paired sample t-test, and Pearson correlation between






1 0.55 (0.28) 0.40 (0.23) 5.95 (11) ⁎⁎ 0.96 ⁎⁎
2 0.48 (0.23) 0.41 (0.23) 1.38 (11) 0.65 ⁎
3 0.28 (0.22) 0.42 (0.23) −9.44 (11) ⁎⁎ 0.98 ⁎⁎
4 0.47 (0.30) 0.41 (0.23) 1.41 (11) 0.89 ⁎⁎
5 0.32 (0.23) 0.42 (0.23) −3.43 (11) ⁎⁎ 0.90 ⁎⁎
6 0.38 (0.23) 0.41 (0.23) −1.43 (11) 0.92 ⁎⁎
7 0.37 (0.40) 0.41 (0.22) −0.59 (11) 0.71 ⁎⁎
8 0.31 (0.21) 0.42 (0.23) −3.70 (11) ⁎⁎ 0.90 ⁎⁎
9 0.44 (0.26) 0.41 (0.23) 1.40 (11) 0.95 ⁎⁎
10 0.50 (0.28) 0.40 (0.23) 2.44 (11) ⁎ 0.86 ⁎⁎
11 0.44 (0.21) 0.41 (0.23) 0.72 (11) 0.84 ⁎⁎
12 0.44 (0.30) 0.41 (0.23) 0.76 (11) 0.85 ⁎⁎
13 0.43 (0.22) 0.41 (0.23) 0.97 (11) 0.94 ⁎⁎
14 0.45 (0.30) 0.41 (0.23) 1.07 (11) 0.88 ⁎⁎
15 0.42 (0.29) 0.42 (0.22) 0.30 (11) 0.95 ⁎⁎
16 0.30 (0.17) 0.42 (0.24) −2.46 (11) ⁎ 0.69 ⁎
N=12.
M = mean.
SD = standard deviation.
R = Pearson correlation between panelist and panel mean.




External consistency. Paired sample t-test and Pearson correlation between






1 0.57 (0.30) 0.41 (0.27) 6.50 (9) ⁎⁎ 0.97 ⁎⁎
2 0.44 (0.23) 0.41 (0.27) 0.44 (9) 0.70 ⁎
3 0.28 (0.24) 0.41 (0.27) −4.73 (9) ⁎⁎ 0.95 ⁎⁎
4 0.49 (0.32) 0.41 (0.27) 1.85 (9) 0.89 ⁎⁎
5 0.31 (0.25) 0.41 (0.27) −3.58 (9) ⁎⁎ 0.95 ⁎⁎
6 0.36 (0.25) 0.41 (0.27) −2.74 (9) ⁎ 0.98 ⁎⁎
7 0.39 (0.43) 0.41 (0.27) −0.19 (9) 0.65 ⁎
8 0.32 (0.23) 0.41 (0.27) −2.11 (9) 0.86 ⁎⁎
9 0.47 (0.29) 0.41 (0.27) 3.64 (9) ⁎⁎ 0.98 ⁎⁎
10 0.49 (0.30) 0.41 (0.27) 1.75 (9) 0.89 ⁎⁎
11 0.45 (0.22) 0.41 (0.27) 0.67 (9) 0.75 ⁎
12 0.43 (0.33) 0.41 (0.27) 0.56 (9) 0.91 ⁎⁎
13 0.42 (0.23) 0.41 (0.27) 0.54 (9) 0.98 ⁎⁎
14 0.46 (0.33) 0.41 (0.27) 1.25 (9) 0.94 ⁎⁎
15 0.41 (0.32) 0.41 (0.27) 0.14 (9) 0.90 ⁎⁎
16 0.30 (0.18) 0.41 (0.27) −1.50 (9) 0.59
N=10.
M = mean.
SD = standard deviation.
r=Pearson correlation between panelist and mean previous studies.
⁎⁎ pb0.01.
⁎ pb0.05.
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most panelists correlate strongly with the mean of the other
panelists (see Table 1). However, some panelists seem to
value health states systematically lower (3, 5 and 8) or
higher (1 and 10), as indicated by a signiﬁcant deviation from
the panel-mean. One panelist (2) correlates less strongly
with the panel-mean, without signiﬁcantly differing from it.
This may indicate that certain health states were valued
higher or lower, but that these differences canceled each
other out. Panelist 16 correlates less strongly with the panel-
mean, but also differs signiﬁcantly from the panel-mean.
Overall, these deviations are too small to be reﬂected in the
Cronbach's α when excluding a panelist. No panelist can
therefore be identiﬁed as an outlier.
3.3. External consistency of the panel
Table 2 shows the paired sample t-tests and Pearson
correlations between the DWs of our panelists and the
corresponding DWs established in previous studies. Correla-
tions are generally strong and the t-tests are not signiﬁcantly
different, indicating a fair external consistency. From Table 3
it becomes apparent that the majority of the DWs from our
panel fall within the 95% conﬁdence intervals (CIs) of
previously estimated DWs. Health states 4, 7, 8 and 10 are
exceptions. The 95% CIs reﬂect the uncertainty of the
estimate, which may lead to an upper or lower bound thatexceeds the theoretical minimum and maximum values of
DWs (0 and 1). Fig. 1 graphically displays the differences.
3.4. Disability weights for suicidality
The DW for suicidal thoughts is estimated to be 0.36
(SD=0.16; 95% CI 0.05; 0.67). Expressed as a utility, this is
0.64 (SD=0.16; 95% CI 0.33; 0.95). For mental distress
Table 3
Agreement between DWs of previous studies and current study.
Health state Previous studies Current study
DW 95% CI DW 95% CI
1 Constitutional eczema 0.07 a 0.01; 0.13 0.08 −0.06; 0.22
2 Cataract 0.11 b 0.09; 0.14 0.14 −0.05; 0.33
3 Meningitis with permanent locomotor impairment 0.17 a 0.04; 0.30 0.25 −0.11; 0.61
4 Macular degeneration 0.25 b 0.21; 0.29 0.33 ⁎ −0.10; 0.76
5 Moderate heart failure 0.35 a 0.19; 0.52 0.35 0.09; 0.61
6 Moderate rheumatoid arthritis 0.37 a 0.22; 0.52 0.33 0.05; 0.61
7 Moderate to severe depression 0.51 c 0.46; 0.56 0.39 ⁎ 0.09; 0.69
8 Severe heart failure 0.65 a 0.60; 0.71 0.75 ⁎ 0.42; 1.08
9 Meningitis with permanent locomotor and cognitive impairment 0.76 a 0.65; 0.87 0.75 0.46; 1.04
10 Severe depression with psychotic features 0.84 c 0.80; 0.88 0.74 ⁎ 0.40; 1.08
CI = conﬁdence interval.
a Stouthard et al. (1997).
b De Hollander et al. (2006).
c Kruijshaar et al. (2005).
⁎ DW outside CI of previous studies.
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(SD=0.13; 95% CI 0.20; 0.72). This corresponds to a utility
of 0.54 (SD=0.13; 95% CI 0.29; 0.79).
4. Discussion
This paper presents the DWs for suicidal thoughts and for
mental distress of non-fatal suicide attempts. It is notable that
our DW for attempted suicide is very similar to the DW
estimated in the Australian burden of disease study for self-
inﬂicted injuries (0.447) (Mathers et al., 1999). In contrast
with the DW for physical injury after a suicide attempt (0.09)
(Hoeymans and Schoemaker, 2010), the DW for mental
distress involved in a non-fatal suicide attempt is relatively
high. This implies that the disability of a non-fatal suicide
attempt is largely attributable to themental distress involved.
When comparing the DW for suicidal thoughts with DWs for
related psychiatric disorders, this shows that suicidal
thoughts (0.36) are about as disabling as alcohol dependence
(0.32) and cocaine dependence (0.33) (Smit et al., 2008). The
DW for mental distress involved in non-fatal suicide attempts
(0.46) is comparable with heroin dependence (0.43) (Smit et al.,





















Previous studies Current study
Fig. 1. Comparison of DWs of previous studies and the current study.tions of depressive disorder (Kruijshaar et al., 2005). Both the
derived DWs are less severe than those for borderline
personality disorder (0.54) (Mathers et al., 1999) and schizo-
phrenia (0.71; several psychotic episodes and some permanent
impairments) (Stouthard et al., 1997). When comparing the
DWs for suicidality with somatic disorders, it becomes apparent
that suicidal thoughts are as disabling as severe asthma (0.36)
and moderate heart failure (0.35) (Stouthard et al., 1997). Non-
fatal suicide attempts match the DW for initial stage Parkinson's
(0.48) (Stouthard et al., 1997). The above comparisons
demonstrate the severity of suicidality.
Suicidality is often co-morbid with or symptomatic of
psychiatric disorders. In general, much more empirical
research is needed to clarify and disentangle comorbidity in
the light of DWs. Currently, there are two ways of dealing
with co-morbidity, but these may not be adequate. The ﬁrst is
by using an additive model in which the DWs of the co-
morbid disorders are simply added. However, this may lead
to an overestimation of the disability and possibly a DW
exceeding 1. A way to overcome this is by using a
multiplicative model. This model assumes that the combina-
tion of two health states is equal to the multiplication of both
DWs belonging to each of the component health states
(DW12=1−(1−DW1)×(1−DW2)) (Mathers et al., 1999).
For example, if a person has alcohol dependence (DW=0.32)
and suicidal thoughts (DW=0.36), the combined DW for
both health states would be 0.56. As suicidality is regarded as
a symptom of depression in the DSM-IV-TR it should be noted
that our panel valued depression less severely than previous
panels (0.39 versus 0.51 for moderate depression and 0.74
versus 0.84 for severe depression). This difference may have
been caused by the implicit assumption of the panelists that
suicidality was excluded from the descriptions of depression
(while this was not the case). In future DW studies, it is
recommended to bear this in mind.
4.1. Future use of the DWs
As stated in the Introduction, DWs are an essential
component in calculating DALYs and related metrics such
as Quality Adjusted Life Years (QALYs; Dolan, 2000). Where
data are available on necessary parameters (incidence and
346 B.A.J. van Spijker et al. / Journal of Affective Disorders 134 (2011) 341–347duration or point prevalence) the DWs estimated in this
study can be used to calculate DALYs for suicidal thoughts and
non-fatal suicide attempts. In the Netherlands, only data on
year-prevalence are available. Using this would generate YLD
of 462,500×0.36=166,500 for suicidal thoughts and of
99,600×0.46=45,800 for non-fatal suicide attempts. Adding
the YLD of physical injury after attempted suicide (1400) and
years of life lost (YLL) due to suicide (43,500) (Hoeymans and
Schoemaker, 2010), would generate a total DALY disease
burden of 257,100 for suicidality. Since no co-morbidity is
taken into account and only data on year prevalence could be
used, this calculation should be regarded as provisional. It
should also be noted that a prevalence-based approach does
not reﬂect recent changes in incidence and is mainly suitable
for providing insight into present needs for health care,
whereas an incidence-based approach would be more
appropriate when estimating the effects of preventive in-
terventions (Melse et al., 2000). Computing the DALY disease
burden due to suicidal thoughts and behaviors would be
valuable in informing debates regarding, for example, priority
setting in health care and research funding.
The complement of the DW, the utility (U), can be used in
calculating Quality Adjusted Life Years (QALYs) (Dolan,
2000). QALY can be described as a year of life, adjusted for
its quality. A year in perfect health is expressed by 1, a year in
ill health by a value between 1 and 0, depending on disease
severity. QALYs are often used in cost-utility analyses of
medical or psychological interventions. Interventions can
then be ranked in terms of the cost of gaining one QALY,
which is of use in decision-making by policymakers and
public health planners. Following from this, DWs or Us can
also be used in cost-effectiveness analyses of interventions,
which provide information about which intervention offers
better value for money than its alternative for gaining one
QALY or avoiding one DALY. However, as mentioned in the
Introduction, underlying assumptions and methodology for
both health metrics have been criticized and should be taken
into account when using the DWs.
4.2. Strengths and limitations
There are several indications that our ﬁndings are valid.
First, the internal consistency of our panel was high,
indicating good agreement among the panelists. Second, a
fair external consistency was found. Furthermore, the
similarity of our DW for non-fatal suicide attempts to the
DW estimated in the Australian burden of disease study
for self-inﬂicted injuries (0.447) (Mathers et al., 1999)
strengthens the reliability of our results.
The limitations of this study include the small panel of 16
experts, which resulted in relatively broad 95% conﬁdence
intervals. Also the fact that there is no standardized description
or deﬁnition available of suicidal thoughts and non-fatal
suicide attempts should be seen as a limitation. Furthermore,
the DWs have been generated by an expert panel, whereas it is
also possible to create a panel from a representative sample of
the general population or people who experienced the health
state directly. There is however no consensus in the literature
on which kind of panel would be preferable. It is important to
realize in this respect that using different kinds of panels may
generate different estimations of the DWs. Patient panels forexample tend to rate health states better than the general
public (Damschroder et al., 2005), and sometimes worse than
expert panels (Suarez-Almazor et al., 2001). The agreement
between expert panels and general public panels seems to be
good (Schwarzinger et al., 2003). The decision to make use of
an expert panel in this studywasmotivated by the fact that the
studies with which we compared our results likewise made
use of expert panels. Another, related, limitation may lie in the
fact that the experts were not asked about personal experi-
ences with any of the valued health states, which may have
biased the results. However, since no outliers were detected in
the analyses, there are no direct indications that any personal
experiences have strongly affected the results. A ﬁnal limita-
tion lies in the fact that the DWs have been generated in aWest
European, high income country, which may limit the gener-
alizability of the ﬁndings.
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